新五丰：10月23日召开董事会会议

Group 1 - The core point of the article is that New Wufeng (SH 600975) held its 19th meeting of the 6th Board of Directors on October 23, 2025, to review the proposal for the company's Q3 2025 report [1] - For the year 2024, New Wufeng's revenue composition is as follows: livestock industry accounts for 76.4%, wholesale and retail accounts for 22.81%, feed processing accounts for 0.69%, and other businesses account for 0.1% [1] - As of the time of reporting, New Wufeng has a market capitalization of 8 billion yuan [1] Group 2 - The article mentions that Chinese innovative drugs have generated $80 billion in overseas licensing this year, highlighting a hot secondary market in biomedicine, while the primary market is facing fundraising challenges [1]